-
Must Watch These 5 Stocks: Merck. (NYSE:MRK), Enanta Pharmaceuticals (NASDAQ:ENTA), Koninklijke Philips (NYSE:PHG), Cepheid (NASDAQ:CPHD), Span-America Medical Systems (NASDAQ:SPAN)
On Dec 22, Merck & Co. Inc. (NYSE:MRK) $9.5 billion Cubist buyout got off to a rocky start when a U.S. court nixed all but one patent covering top-seller Cubicin. And now, it’ll be up to brand-new FDA approval Zerbaxa to turn things around. Merck & Co. Inc. (NYSE:MRK) in last trading activity moved up…
-
Hot Watch List: Hewlett-Packard Company (NYSE:HPQ), Enanta Pharmaceuticals (NASDAQ:ENTA), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Oplink Communications (NASDAQ:OPLK), HomeAway (NASDAQ:AWAY)
Hewlett-Packard Company (NYSE:HPQ) EVP Martin Fink sold 4,964 shares of the company’s stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $37.20, for a total value of $184,660.80. Following the transaction, the executive vice president now directly owns 1,194 shares of the company’s stock, valued at approximately…
-
Traders Are Gambling on: Enanta Pharmaceuticals (NASDAQ:ENTA), Navidea Biopharmaceuticals, Inc (NYSEMKT:NAVB), L Brands (NYSE:LB), AutoNation Inc. (NYSE:AN), Ericsson (NASDAQ:ERIC)
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) has announced that the U.S. Food and Drug Administration has approved AbbVie’s VIEKIRA PAK(TM) for the Treatment of Chronic Genotype 1 Hepatitis C Virus. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity moved up 10.08% to close at $51.32. Company weekly performance is 19.04% while its quarterly performance stands at 32.99%.…
-
Mix Sector Stocks News: Tesla Motors Inc (NASDAQ:TSLA), Diplomat Pharmacy (NYSE:DPLO), United-Guardian Inc. (NASDAQ:UG), Enanta Pharmaceuticals (NASDAQ:ENTA), THL Credit (NASDAQ:TCRD)
Tesla Motors Inc (NASDAQ:TSLA) said Friday in a corporate blog post that it will install its first battery swap facility in California and invite some owners of the Model S electric sedan to participate at a “cost slightly less than a full tank of gasoline for a premium sedan.” Tesla Motors Inc (NASDAQ:TSLA) in last…
-
Big Moves in Focus: Enanta Pharmaceuticals (NASDAQ:ENTA), Boston Scientific (NYSE:BSX), Argo Group International (NASDAQ:AGII), International Business Machines (NYSE:IBM), ID Systems (NASDAQ:IDSY)
Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay R. Luly sold 15,000 shares of the stock in a transaction dated Monday, December 1st. The stock was sold at an average price of $45.39, for a total transaction of $680,850.00. Following the transaction, the chief executive officer now directly owns 514,338 shares in the company, valued at approximately $23,345,802.Enanta…
-
Top Morning News: Fifth Third Bancorp (NASDAQ:FITB), KeyCorp. (NYSE:KEY), Community Health Systems (NYSE:CYH), Stock Building Supply Holdings (NASDAQ:STCK), Enanta Pharmaceuticals (NASDAQ:ENTA)
Fifth Third Bancorp (NASDAQ:FITB) will present at the Goldman Sachs U.S. Financial Services Conference in New York City on Tuesday, December 9 at approximately 2:40 PM ET.Fifth Third Bancorp (NASDAQ:FITB) in last trading activity moved up 2.33% to close at $20.63. Company weekly performance is 2.53% while its quarterly performance stands at 2.03%. Fifth Third…
-
Investors Watch List: Enanta Pharmaceuticals (NASDAQ:ENTA), Weibo Corporation (NASDAQ:WB), Stewart Information Services Corporation (NYSE:STC), China Telecom Corp (NYSE:CHA), HFF (NYSE:HF)
Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) Monday reported fourth-quarter net loss of $5 million or $0.27 per share compared with $4.4 million or $0.25 per share last year. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity moved up 5.82% to close at $47.99. Company weekly performance is 9.32% while its quarterly performance stands at 9.49%. Enanta Pharmaceuticals,…
-
Top News: Texas Instruments Inc. (NASDAQ:TXN), Enanta Pharmaceuticals (NASDAQ:ENTA), 8×8 Inc. (NASDAQ:EGHT), Teleflex Incorporated (NYSE:TFX), Viad Corp (NYSE:VVI)
As of 3Q14, Texas Instruments Inc. (NASDAQ:TXN) generated an operating cash flow of $2.62 billion. It holds cash and short-term investments worth $3.19 billion and carries a total debt of $4.64 billion. The company has decent cash reserves. Until 2011, the company had no debt on its books. But in order to pay $6.5 billion…
-
Morning Watch List: Enanta Pharmaceuticals (NASDAQ:ENTA), Halliburton Company (NYSE:HAL), Boston Scientific Corporation (NYSE:BSX), Emerald Oil (NYSEMKT:EOX), Colony Financial (NYSE:CLNY)
The results of the studies conducted by Enanta Pharmaceuticals Inc. (NASDAQ:ENTA) on chronic hepatitis C virus (HCV) patients with human immunodeficiency virus type 1 (HIV-1) co-infection (TURQUOISE-I) and liver transplant recipients (CORAL-I) have been presented at The Liver Meeting 2014. Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) in last trading activity fell -0.21% to close at $43.22. Company…